Cardinal Health: stocks, financial statements

Disable ads for free
Dividends News
Favorites

Cardinal Health, Inc. engages in the provision of pharmaceutical and medical products. It operates through the Pharmaceutical and Medical segments. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The company was founded by Robert D. Walter in 1971 and is headquartered in Dublin, OH.

  • CAH Ticker
  • NYSE Exchange
  • 50,200 Employees
8 rated
  • $56.34, +$0.24 (+0.43%) Previous Close
  • 2,137,138 Previous Volume
  • $43.44 / $62.47 52 week low / high
  • -9.81% Percent off 52 week high
  • 2021-05-14 Updated
  • 3.45% Dividend Yield (trailing)
  • 3.48% Dividend Yield (forward)
  • 0 Public float
  • 290,147,927 Outstanding shares
  • 14.14 P/E
  • 16.28 B Market Cap
Disable ads for free

Financial statements — Cardinal Health

The information is not 100% up-to-date. There may be errors or missing information. Some information is often missing, and, although there are almost no errors, I can't rule them out. Right now, I'm looking for a supplier of high-quality information, but so far what I'm finding is expensive (about $2000 a year). You can help my project here.
20 ← 16 2020 2019 2018 2017 2016
Total Revenue
150B 150B 140B 130B 120B
Cost Of Revenue
150B 140B 130B 120B 120B
Gross Profit
6.9B 6.8B 7.2B 6.5B 6.5B
Research and Development
0 0 0 0 0
Selling General and Admin
4.6B 4.5B 4.6B 3.8B 3.6B
Operating Expense
150B 140B 130B 130B 120B
Operating Income
1.8B 1.7B 1.9B 2.2B 2.4B
Other Income Expense Net
0 0 0 0 0
EBIT
1.8B 1.7B 1.9B 2.2B 2.4B
Interest Income
240M 290M 330M 200M 180M
Pretax Income
-3.8B 1.8B -230M 1.9B 2.3B
Income Tax
-79M 390M -490M 630M 850M
Minority Interest
3M 2M 3M 6M 4M
Net Income
-3.7B 1.4B 260M 1.3B 1.4B
Net Income Basic
-3.7B 1.4B 260M 1.3B 1.4B
20 ← 16 2020 2019 2018 2017 2016
Current cash
2.8B 2.5B 1.8B 6.9B 2.4B
Short term investments
1.7B 1.9B 1.9B 2.1B 1.6B
Receivables
8.3B 8.4B 7.8B 8B 7.4B
Inventory
13B 13B 12B 11B 11B
Other current assets
1.7B 1.9B 1.9B 2.1B 1.6B
Current assets
26B 26B 25B 28B 22B
Long term investments
15B 15B 15B 12B 12B
Property plant equipment
2.4B 2.4B 2.5B 1.9B 1.8B
Goodwill
0 0 0 0 0
Intangible assets
11B 12B 12B 9.2B 9.4B
Other assets
1.2B 1.1B 680M 680M 940M
Total assets
41B 41B 40B 40B 34B
Accounts payable
21B 22B 20B 18B 17B
Current long term debt
10M 450M 1B 1.3B 590M
Other current liabilities
2.2B 2.1B 2.2B 2B 1.8B
Total current liabilities
24B 24B 23B 21B 20B
Long term debt
6.8B 7.6B 8B 9.1B 5B
Other liabilities
8.6B 2.9B 3B 2.9B 2.8B
Minority Interest
3M 2M 12M 140M 130M
Total Liabilities
39B 35B 34B 33B 28B
Common stock
290M 300M 310M 320M 330M
Retained earning
1.2B 5.4B 4.6B 5B 6.4B
Treasury stock
-2.1B -1.8B -1.2B -730M -2.8B
Capital surplus
Shareholder equity
1.8B 6.3B 6.1B 6.8B 6.6B
Net tangible assets
-9.5B -5.5B -6.2B -2.4B -2.9B
20 ← 16 2020 2019 2018 2017 2016
Net Income
-3.7B 1.4B 260M 1.3B 1.4B
Depreciation
910M 1B 1B 720M 640M
Changes in receivables
-180M 650M -250M 640M 880M
Changes in inventories
380M 510M 1B 690M 1.4B
Cash change
240M 770M -5.1B 4.5B -2.3B
Cash flow
2B 2.7B 2.8B 1.2B 3B
Capital expenditures
-380M -330M -380M -390M -470M
Investments
Investing activity other
Total investing cash flows
-490M -340M -5.6B -410M -4.1B
Dividends paid
Net borrowings
2.3B 3.6B 5.3B 1.4B 1.6B
Other financing cash flows
Cash flow financing
-2.2B -2.3B -2.3B 3.7B -1.1B
Exchange rate effect
Disable ads for free
Disable ads for free